aTYR PHARMA (ATYR) Notes Payables (2014 - 2015)

aTYR PHARMA (ATYR) has reported Notes Payables for 2 consecutive years, with $2.0 million the latest figure, recorded in Q1 2015.

• For the quarter ending Q1 2015, Notes Payables changed N/A year-over-year to $2.0 million; the trailing twelve-month figure through Mar 2015 stood at $2.0 million (changed N/A YoY), and the FY2014 full-year result was $2.0 million, changed N/A from the prior year.
• Notes Payables held at $2.0 million in Q1 2015 per ATYR's latest filing, from $2.0 million in the prior quarter.
• Across five years, Notes Payables topped out at $2.0 million in Q4 2014 and bottomed at $2.0 million in Q4 2014.